Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (466)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
20
2023
352
2.970
 Why?
Anus Neoplasms
10
2023
24
2.150
 Why?
Stroke
7
2024
495
1.820
 Why?
Acquired Immunodeficiency Syndrome
11
2022
53
1.620
 Why?
Prostatic Hyperplasia
10
2015
39
1.460
 Why?
Brain
9
2024
1319
1.400
 Why?
Parkinson Disease
2
2023
160
1.260
 Why?
Randomized Controlled Trials as Topic
8
2024
573
1.240
 Why?
Chlamydia Infections
8
2017
75
1.220
 Why?
Sarcoma, Kaposi
12
2022
75
1.060
 Why?
Papillomavirus Infections
5
2022
168
1.030
 Why?
Chlamydia trachomatis
6
2017
29
1.030
 Why?
Lymphoma, AIDS-Related
10
2020
16
1.000
 Why?
Brain Ischemia
2
2023
164
0.910
 Why?
Plant Extracts
5
2013
174
0.910
 Why?
Mesenchymal Stem Cell Transplantation
1
2024
19
0.900
 Why?
Humans
102
2025
50503
0.870
 Why?
Serenoa
5
2013
7
0.870
 Why?
Rural Population
4
2023
554
0.800
 Why?
Phytotherapy
3
2012
45
0.800
 Why?
Umbilical Cord
2
2020
34
0.790
 Why?
Lymphoma, Non-Hodgkin
6
2021
55
0.730
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1000
0.720
 Why?
Middle Aged
50
2021
12611
0.710
 Why?
Research Design
5
2022
353
0.690
 Why?
Rats
9
2024
3292
0.670
 Why?
Male
61
2024
25907
0.660
 Why?
Fetal Blood
2
2019
66
0.660
 Why?
Neonatal Abstinence Syndrome
3
2024
28
0.660
 Why?
Infarction, Middle Cerebral Artery
4
2024
40
0.630
 Why?
Adult
48
2022
13577
0.630
 Why?
Inflammation
3
2021
610
0.630
 Why?
Patient Participation
1
2018
70
0.590
 Why?
Vaginosis, Bacterial
2
2015
8
0.560
 Why?
Decision Making
1
2018
272
0.520
 Why?
Neoplasms
3
2023
1251
0.520
 Why?
Mammography
1
2016
101
0.510
 Why?
Stem Cells
3
2025
166
0.510
 Why?
Female
48
2024
27081
0.500
 Why?
Antineoplastic Agents
9
2023
1172
0.500
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
45
0.480
 Why?
Aged
28
2020
9741
0.480
 Why?
Animals
16
2025
13124
0.470
 Why?
Population Density
1
2014
15
0.470
 Why?
Pelvic Inflammatory Disease
2
2018
8
0.470
 Why?
AIDS-Related Opportunistic Infections
5
2016
38
0.470
 Why?
Stem Cell Transplantation
4
2025
179
0.460
 Why?
Carcinoma in Situ
3
2013
73
0.450
 Why?
Rats, Sprague-Dawley
7
2024
1585
0.450
 Why?
Cytokines
5
2023
606
0.440
 Why?
Anti-Bacterial Agents
5
2020
745
0.440
 Why?
Uterine Cervicitis
1
2013
3
0.430
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.420
 Why?
Urethritis
2
2012
5
0.420
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
90
0.410
 Why?
Finasteride
4
2015
4
0.400
 Why?
Research Subjects
1
2013
51
0.400
 Why?
Guideline Adherence
1
2013
136
0.400
 Why?
Subarachnoid Hemorrhage
1
2012
65
0.390
 Why?
Breast Neoplasms
3
2017
1201
0.390
 Why?
Patient Dropouts
1
2012
52
0.380
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
154
0.380
 Why?
Urologic Diseases
1
2011
10
0.370
 Why?
HIV-1
6
2020
54
0.370
 Why?
Analgesics, Opioid
4
2024
575
0.360
 Why?
Lung Neoplasms
2
2013
601
0.360
 Why?
Disease Models, Animal
5
2024
1436
0.350
 Why?
United States
10
2023
4955
0.340
 Why?
Patient Selection
1
2011
259
0.330
 Why?
Young Adult
16
2018
4102
0.330
 Why?
Quality of Life
6
2024
851
0.330
 Why?
Asthma
2
2024
284
0.330
 Why?
Lymphedema
2
2022
46
0.320
 Why?
HIV Seropositivity
3
2021
26
0.320
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.320
 Why?
Intestinal Mucosa
2
2021
216
0.320
 Why?
Polymorphism, Single Nucleotide
3
2017
475
0.300
 Why?
Gonorrhea
2
2020
9
0.300
 Why?
Azithromycin
4
2020
25
0.290
 Why?
Risk Factors
8
2022
3724
0.280
 Why?
Th1 Cells
2
2017
53
0.280
 Why?
Vascular Endothelial Growth Factor A
4
2017
182
0.260
 Why?
Treatment Outcome
17
2020
5283
0.260
 Why?
Mycoplasma genitalium
2
2018
2
0.250
 Why?
Doxazosin
3
2015
3
0.250
 Why?
Mycoplasma Infections
2
2018
7
0.250
 Why?
Anti-Infective Agents
2
2020
95
0.250
 Why?
Prospective Studies
11
2022
2378
0.250
 Why?
Cyclophosphamide
9
2021
168
0.250
 Why?
Doxycycline
3
2015
32
0.250
 Why?
Cancer Vaccines
1
2006
80
0.250
 Why?
Vincristine
8
2021
82
0.240
 Why?
Multicenter Studies as Topic
4
2024
89
0.240
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
578
0.240
 Why?
Circadian Rhythm
1
2025
89
0.230
 Why?
Adolescent
13
2022
6443
0.230
 Why?
Air Filters
1
2024
1
0.230
 Why?
Double-Blind Method
4
2013
708
0.230
 Why?
Thymus Gland
2
2021
42
0.230
 Why?
Air Pollution, Indoor
1
2024
25
0.220
 Why?
CD4 Lymphocyte Count
7
2020
32
0.220
 Why?
Bronchiolitis
1
2024
27
0.220
 Why?
Prevalence
6
2021
971
0.220
 Why?
5-alpha Reductase Inhibitors
2
2015
3
0.220
 Why?
Hyperbaric Oxygenation
1
2023
15
0.220
 Why?
Homosexuality, Male
3
2022
51
0.220
 Why?
Cell Differentiation
3
2025
640
0.220
 Why?
Substantia Nigra
1
2023
13
0.220
 Why?
alpha-Synuclein
1
2023
10
0.220
 Why?
Doxorubicin
8
2021
236
0.210
 Why?
Nervous System Diseases
1
2024
89
0.210
 Why?
Transplantation Conditioning
2
2018
87
0.210
 Why?
Tumor Necrosis Factor-alpha
2
2017
393
0.210
 Why?
Informatics
1
2023
8
0.210
 Why?
Prednisone
7
2021
101
0.210
 Why?
Herpesvirus 8, Human
5
2020
97
0.210
 Why?
Cross-Sectional Studies
3
2021
1610
0.200
 Why?
Follow-Up Studies
8
2019
2242
0.200
 Why?
Astrocytes
1
2024
145
0.200
 Why?
Brachytherapy
1
2022
46
0.200
 Why?
Child
8
2024
6906
0.200
 Why?
Watchful Waiting
1
2022
26
0.200
 Why?
Medical Records
1
2022
85
0.200
 Why?
Feasibility Studies
2
2021
390
0.200
 Why?
Absorptiometry, Photon
1
2003
155
0.200
 Why?
Substance Withdrawal Syndrome
1
2023
168
0.200
 Why?
Genome-Wide Association Study
3
2018
163
0.190
 Why?
Vitamin D Deficiency
1
2022
44
0.190
 Why?
Brain Injuries
1
2023
159
0.190
 Why?
Viral Load
6
2020
76
0.190
 Why?
Vaccines
1
2022
50
0.190
 Why?
Precancerous Conditions
1
2022
82
0.190
 Why?
Case-Control Studies
3
2014
1156
0.190
 Why?
Lymphocyte Activation
3
2017
164
0.190
 Why?
Mouth Diseases
1
2021
5
0.190
 Why?
Clinical Trials as Topic
5
2020
486
0.190
 Why?
Vaccination
3
2022
280
0.190
 Why?
Papillomaviridae
2
2016
103
0.190
 Why?
Mass Screening
2
2015
344
0.190
 Why?
Neoplasm Staging
4
2022
746
0.180
 Why?
Pluripotent Stem Cells
1
2021
6
0.180
 Why?
Physical Conditioning, Animal
1
2021
57
0.180
 Why?
Primary Health Care
2
2022
366
0.180
 Why?
Drug Therapy, Combination
5
2015
384
0.180
 Why?
T-Lymphocyte Subsets
2
2017
39
0.180
 Why?
Papillomavirus Vaccines
2
2013
67
0.180
 Why?
Vagina
2
2018
43
0.180
 Why?
Etoposide
5
2021
77
0.180
 Why?
Anti-HIV Agents
3
2020
42
0.180
 Why?
Spleen
1
2021
169
0.180
 Why?
Enzyme Inhibitors
2
2016
377
0.180
 Why?
Cross-Over Studies
1
2021
228
0.180
 Why?
Genes, myc
1
2020
32
0.170
 Why?
Gene Frequency
2
2017
97
0.170
 Why?
Overweight
1
2022
215
0.170
 Why?
Transplantation, Autologous
3
2018
481
0.170
 Why?
Aged, 80 and over
5
2013
3226
0.170
 Why?
Uterine Cervical Neoplasms
1
2022
276
0.170
 Why?
Dihydroxyphenylalanine
1
2019
5
0.160
 Why?
Dopaminergic Neurons
1
2019
18
0.160
 Why?
Empathy
1
2019
48
0.160
 Why?
Ablation Techniques
1
2019
22
0.160
 Why?
Infant, Newborn
5
2024
2749
0.160
 Why?
Social Environment
1
2019
79
0.160
 Why?
Altruism
1
2018
12
0.160
 Why?
Sodium, Dietary
1
2019
24
0.160
 Why?
Central Nervous System Diseases
1
2019
25
0.160
 Why?
Mitochondria
2
2020
399
0.150
 Why?
Asymptomatic Infections
1
2018
4
0.150
 Why?
Antiviral Agents
2
2013
170
0.150
 Why?
Dopamine
1
2019
175
0.150
 Why?
Acoustic Stimulation
1
2018
93
0.150
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
234
0.150
 Why?
Sexually Transmitted Diseases
1
2018
36
0.150
 Why?
Protein Kinase Inhibitors
2
2023
204
0.150
 Why?
Energy Metabolism
1
2020
286
0.150
 Why?
Hyperthermia, Induced
1
2019
115
0.150
 Why?
Chlamydia
1
2017
8
0.140
 Why?
Mucous Membrane
1
2017
28
0.140
 Why?
Biopsy
2
2022
588
0.140
 Why?
Pilot Projects
3
2019
698
0.140
 Why?
Blood Cells
1
2017
47
0.140
 Why?
Genetic Predisposition to Disease
2
2018
511
0.140
 Why?
Antibodies, Bacterial
1
2017
27
0.140
 Why?
DNA, Circular
1
2017
18
0.140
 Why?
Clostridium Infections
1
2018
55
0.140
 Why?
Clonal Evolution
1
2017
56
0.140
 Why?
Immunoglobulins
1
2017
81
0.140
 Why?
Immunoglobulin G
1
2017
190
0.130
 Why?
Anus Diseases
1
2016
2
0.130
 Why?
Sentinel Lymph Node Biopsy
1
2017
118
0.130
 Why?
Telemedicine
1
2022
469
0.130
 Why?
Mannitol
1
2016
15
0.130
 Why?
Lymph Node Excision
1
2017
131
0.130
 Why?
Thiazoles
1
2016
53
0.130
 Why?
Guidelines as Topic
1
2016
109
0.130
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.130
 Why?
Diagnostic Self Evaluation
1
2015
14
0.130
 Why?
Comorbidity
2
2018
623
0.130
 Why?
Blood-Brain Barrier
1
2016
47
0.130
 Why?
Anal Canal
3
2023
21
0.130
 Why?
CD4-Positive T-Lymphocytes
1
2017
158
0.120
 Why?
Dose-Response Relationship, Drug
4
2013
1372
0.120
 Why?
T-Lymphocytes
1
2017
325
0.120
 Why?
Educational Status
1
2016
230
0.120
 Why?
Tinidazole
2
2012
2
0.120
 Why?
Burkitt Lymphoma
1
2015
14
0.120
 Why?
Imidazoles
1
2016
127
0.120
 Why?
Drug Administration Schedule
5
2020
370
0.120
 Why?
Lymph Nodes
1
2017
257
0.120
 Why?
Menarche
1
2014
7
0.120
 Why?
Data Collection
3
2023
280
0.120
 Why?
Stomatitis
1
2014
16
0.120
 Why?
Chromosomes, Human, Pair 2
1
2014
21
0.120
 Why?
Obesity
3
2022
1121
0.120
 Why?
Immunophenotyping
2
2017
105
0.120
 Why?
Disease-Free Survival
5
2016
444
0.110
 Why?
Hypogonadism
1
2013
10
0.110
 Why?
Benzamides
1
2013
50
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
326
0.110
 Why?
Incidence
4
2018
1032
0.110
 Why?
Urban Population
1
2014
151
0.110
 Why?
SEER Program
1
2013
94
0.110
 Why?
Health Surveys
1
2014
239
0.110
 Why?
Regenerative Medicine
2
2025
10
0.110
 Why?
Stress Disorders, Post-Traumatic
1
2018
383
0.110
 Why?
Organophosphonates
1
2013
7
0.110
 Why?
Heart Failure
1
2019
528
0.110
 Why?
Perineum
1
2013
24
0.110
 Why?
Testosterone
1
2013
145
0.100
 Why?
DNA, Viral
3
2020
136
0.100
 Why?
Placebos
1
2013
87
0.100
 Why?
Stress, Psychological
2
2019
266
0.100
 Why?
Cytosine
1
2013
30
0.100
 Why?
Adrenergic alpha-Antagonists
2
2009
27
0.100
 Why?
tau Proteins
1
2012
29
0.100
 Why?
Piperazines
1
2013
119
0.100
 Why?
Prostate
2
2015
114
0.100
 Why?
HIV
3
2023
25
0.100
 Why?
Trichomonas Infections
1
2012
2
0.100
 Why?
Trichomonas vaginalis
1
2012
3
0.100
 Why?
Transforming Growth Factor beta1
1
2012
60
0.100
 Why?
Pyrimidines
1
2013
191
0.100
 Why?
Sleep
2
2024
181
0.100
 Why?
Vulvar Neoplasms
1
2013
58
0.100
 Why?
Time Factors
5
2023
2935
0.100
 Why?
Medicare
1
2013
247
0.100
 Why?
Androgen Antagonists
1
2011
11
0.100
 Why?
Urination Disorders
1
2011
23
0.100
 Why?
Sirolimus
1
2012
62
0.100
 Why?
Antibiotics, Antineoplastic
1
2012
77
0.090
 Why?
CD8-Positive T-Lymphocytes
2
2017
125
0.090
 Why?
Kenya
2
2022
10
0.090
 Why?
Quinazolinones
1
2011
6
0.090
 Why?
Human papillomavirus 16
2
2013
44
0.090
 Why?
Arkansas
1
2016
1985
0.090
 Why?
Practice Guidelines as Topic
1
2013
468
0.090
 Why?
Social Class
1
2011
94
0.090
 Why?
Prognosis
5
2017
1978
0.090
 Why?
Multivariate Analysis
1
2012
583
0.090
 Why?
Chronic Disease
1
2012
573
0.090
 Why?
Methotrexate
2
2015
72
0.090
 Why?
Piperidines
1
2011
99
0.090
 Why?
Plant Bark
1
2009
6
0.080
 Why?
Valproic Acid
1
2009
31
0.080
 Why?
Multiple Myeloma
2
2014
2998
0.080
 Why?
Colorectal Neoplasms
1
2013
260
0.080
 Why?
Ki-67 Antigen
1
2009
56
0.080
 Why?
Socioeconomic Factors
1
2012
591
0.080
 Why?
India
2
2021
53
0.080
 Why?
Logistic Models
1
2012
900
0.080
 Why?
Fruit
1
2009
119
0.080
 Why?
Tetracyclines
2
2006
9
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
629
0.080
 Why?
Cisplatin
2
2022
286
0.070
 Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
 Why?
Survival Analysis
3
2017
661
0.070
 Why?
Glomerulonephritis, IGA
1
2007
5
0.070
 Why?
Galactose
1
2007
28
0.070
 Why?
Immunoglobulin A
1
2007
44
0.070
 Why?
Adaptive Immunity
2
2017
32
0.070
 Why?
Glioblastoma
1
2009
94
0.070
 Why?
Sexual Partners
2
2018
30
0.070
 Why?
Disease Progression
4
2013
829
0.070
 Why?
Regression Analysis
2
2018
382
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Lymphocyte Count
1
2006
19
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
31
0.070
 Why?
Sexual Behavior
2
2018
117
0.070
 Why?
Viral Vaccines
1
2006
12
0.070
 Why?
HIV Protease Inhibitors
1
2006
2
0.070
 Why?
Immunohistochemistry
3
2017
957
0.070
 Why?
Interferon-alpha
1
2006
47
0.060
 Why?
Infant
2
2024
3628
0.060
 Why?
Nephrosis, Lipoid
1
2005
5
0.060
 Why?
Arterioles
1
2005
34
0.060
 Why?
Severity of Illness Index
2
2023
978
0.060
 Why?
Brain Neoplasms
1
2009
291
0.060
 Why?
Body Mass Index
2
2022
677
0.060
 Why?
Recombinant Fusion Proteins
1
2006
179
0.060
 Why?
Circadian Clocks
1
2025
1
0.060
 Why?
Matrix Metalloproteinase 9
3
2017
88
0.060
 Why?
Administration, Oral
4
2013
434
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Administration, Intranasal
1
2024
30
0.060
 Why?
Phenotype
2
2017
739
0.060
 Why?
Leucovorin
1
2004
20
0.060
 Why?
Purines
1
2004
37
0.060
 Why?
Genotype
2
2017
533
0.060
 Why?
Neutropenia
2
2020
116
0.060
 Why?
Confidence Intervals
2
2015
154
0.060
 Why?
Dust
1
2024
22
0.060
 Why?
Particulate Matter
1
2024
54
0.060
 Why?
Carbon
1
2024
55
0.060
 Why?
Arthritis, Rheumatoid
1
2004
106
0.060
 Why?
Folic Acid
1
2004
139
0.050
 Why?
Cytochrome P-450 CYP3A
1
2023
77
0.050
 Why?
Femur Neck
1
2003
6
0.050
 Why?
Africa South of the Sahara
1
2022
5
0.050
 Why?
Hip
1
2003
25
0.050
 Why?
Bacterial Proteins
1
2006
367
0.050
 Why?
Drug Delivery Systems
1
2024
143
0.050
 Why?
Quality Control
1
2003
98
0.050
 Why?
Narcotics
1
2023
112
0.050
 Why?
Sample Size
1
2022
39
0.050
 Why?
Breast Feeding
1
2024
189
0.050
 Why?
Eating
1
2023
158
0.050
 Why?
Vitamins
1
2022
63
0.050
 Why?
Femur
1
2003
130
0.050
 Why?
Spine
1
2003
90
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
10
0.050
 Why?
Tetracycline
1
2002
20
0.050
 Why?
Radiotherapy Dosage
1
2022
248
0.050
 Why?
Vitamin D
1
2022
87
0.050
 Why?
Tretinoin
1
2002
50
0.050
 Why?
Leg
1
2022
123
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
34
0.050
 Why?
Antibodies, Monoclonal
1
2005
462
0.050
 Why?
Museums
1
2021
2
0.050
 Why?
Alprostadil
1
2021
10
0.050
 Why?
Length of Stay
1
2024
629
0.040
 Why?
Oxygen
1
2023
321
0.040
 Why?
Kidney
1
2005
696
0.040
 Why?
Zimbabwe
1
2020
3
0.040
 Why?
Malawi
1
2020
12
0.040
 Why?
Uganda
1
2020
35
0.040
 Why?
Wharton Jelly
1
2020
1
0.040
 Why?
Software
1
2003
276
0.040
 Why?
Body Composition
1
2003
327
0.040
 Why?
Herpesvirus 4, Human
1
2020
37
0.040
 Why?
Cell Shape
1
2020
20
0.040
 Why?
Neisseria gonorrhoeae
1
2020
4
0.040
 Why?
Herpesviridae Infections
1
2020
54
0.040
 Why?
Ceftriaxone
1
2020
24
0.040
 Why?
Histone Deacetylase Inhibitors
1
2020
56
0.040
 Why?
B-Lymphocytes
1
2021
171
0.040
 Why?
Thrombocytopenia
1
2020
81
0.040
 Why?
Drug Resistance, Bacterial
1
2020
72
0.040
 Why?
Cohort Studies
2
2018
1452
0.040
 Why?
Interleukin-6
2
2016
261
0.040
 Why?
Remission Induction
2
2012
208
0.040
 Why?
Proctoscopy
1
2019
2
0.040
 Why?
Kaplan-Meier Estimate
1
2020
464
0.040
 Why?
Microbial Sensitivity Tests
1
2020
269
0.040
 Why?
Cell Survival
1
2020
589
0.040
 Why?
Masks
1
2018
30
0.040
 Why?
Statistics, Nonparametric
2
2013
192
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Models, Animal
1
2019
227
0.040
 Why?
Coinfection
1
2018
41
0.040
 Why?
Neurodegenerative Diseases
1
2019
77
0.040
 Why?
Pandemics
1
2022
563
0.040
 Why?
Bone Marrow
1
2019
363
0.040
 Why?
Neurogenesis
1
2017
25
0.040
 Why?
Cell Separation
1
2017
92
0.040
 Why?
Cytological Techniques
1
2017
14
0.040
 Why?
Angiopoietin-2
1
2017
15
0.030
 Why?
Interleukin-2
1
2017
71
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Axilla
1
2017
91
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
45
0.030
 Why?
Staining and Labeling
1
2017
96
0.030
 Why?
Fluorouracil
1
2016
58
0.030
 Why?
Gene Rearrangement
1
2017
65
0.030
 Why?
Biopsy, Needle
1
2017
178
0.030
 Why?
Odds Ratio
1
2018
551
0.030
 Why?
Neuroprotective Agents
1
2017
99
0.030
 Why?
Membrane Glycoproteins
1
2017
245
0.030
 Why?
Interferon-gamma
1
2017
177
0.030
 Why?
Chemoradiotherapy
1
2016
42
0.030
 Why?
Cord Blood Stem Cell Transplantation
1
2016
5
0.030
 Why?
Mastectomy
1
2017
142
0.030
 Why?
Directly Observed Therapy
1
2015
7
0.030
 Why?
Urine
1
2015
24
0.030
 Why?
RNA, Viral
2
2009
107
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
17
0.030
 Why?
Vaginal Smears
1
2015
28
0.030
 Why?
Neovascularization, Pathologic
1
2017
155
0.030
 Why?
Neoadjuvant Therapy
1
2017
120
0.030
 Why?
Treatment Failure
1
2015
118
0.030
 Why?
Prisons
1
2015
37
0.030
 Why?
Ifosfamide
1
2015
11
0.030
 Why?
Cytarabine
1
2015
37
0.030
 Why?
Flow Cytometry
1
2017
474
0.030
 Why?
Induction Chemotherapy
1
2014
59
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
59
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
 Why?
Depression
1
2019
582
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
34
0.030
 Why?
Melphalan
1
2014
178
0.030
 Why?
Statistics as Topic
1
2013
88
0.030
 Why?
Cancer Care Facilities
1
2013
18
0.030
 Why?
Time
1
2013
28
0.030
 Why?
Gene Expression Regulation
1
2017
955
0.030
 Why?
Administration, Cutaneous
1
2013
55
0.030
 Why?
Infusions, Intravenous
1
2013
213
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
123
0.030
 Why?
Demography
1
2013
94
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
59
0.030
 Why?
Antitrichomonal Agents
1
2012
1
0.030
 Why?
Risk Assessment
1
2017
1270
0.030
 Why?
Combined Modality Therapy
1
2014
641
0.030
 Why?
Reference Values
1
2013
307
0.020
 Why?
Polyethylene Glycols
1
2012
86
0.020
 Why?
Antigens, Viral
1
2012
42
0.020
 Why?
Medical Oncology
1
2013
98
0.020
 Why?
Administration, Topical
1
2011
57
0.020
 Why?
Single-Blind Method
1
2011
114
0.020
 Why?
Neoplasm Proteins
1
2013
320
0.020
 Why?
Sex Factors
1
2013
712
0.020
 Why?
Organ Size
1
2011
223
0.020
 Why?
Retrospective Studies
1
2022
6263
0.020
 Why?
Antibodies, Viral
1
2010
94
0.020
 Why?
Survival Rate
1
2012
909
0.020
 Why?
Anti-Retroviral Agents
1
2008
13
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
318
0.020
 Why?
Busulfan
1
2008
19
0.020
 Why?
Mutation
1
2013
1280
0.020
 Why?
Lectins
1
2007
14
0.020
 Why?
Psychometrics
1
2009
232
0.020
 Why?
Glycosylation
1
2007
102
0.020
 Why?
Mice
1
2017
5687
0.020
 Why?
Ultrasonography
1
2008
435
0.020
 Why?
Maximum Tolerated Dose
1
2006
39
0.020
 Why?
Injections, Subcutaneous
1
2006
52
0.020
 Why?
Hypertension, Renal
1
2005
23
0.020
 Why?
Cell Proliferation
1
2009
985
0.020
 Why?
Fatigue
1
2006
127
0.020
 Why?
Pyridoxine
1
2004
4
0.010
 Why?
Ribonucleotides
1
2004
6
0.010
 Why?
Vitamin B 12
1
2004
30
0.010
 Why?
Recombinant Proteins
1
2006
476
0.010
 Why?
Erythrocytes
1
2004
83
0.010
 Why?
Adenosine
1
2004
71
0.010
 Why?
Homocysteine
1
2004
127
0.010
 Why?
Receptors, Interleukin-6
1
2002
22
0.010
 Why?
Endothelial Growth Factors
1
2002
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
13
0.010
 Why?
Lymphokines
1
2002
19
0.010
 Why?
Drug Tolerance
1
2002
60
0.010
 Why?
Safety
1
2002
77
0.010
 Why?
Child, Preschool
1
2005
3942
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (466) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department